# Advisor Review - Advisor 2/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-24T10:34:11.937819
**Response ID:** resp_0187734c39a621de006974917255a881a0aa583dc8d9b72691
**Tokens:** 7933 in / 4079 out
**Response SHA256:** 04951c3a52c41591

---

I checked the draft for **fatal** issues in the four categories you specified (data–design alignment, regression sanity, completeness, internal consistency). Based on the excerpt you provided (Tables 1–3; Figures 1–3; Sections 1–7; Appendices A–C), I do **not** see any fatal errors that would make the design impossible, the outputs obviously broken, the draft incomplete, or the key numbers internally inconsistent.

Key “sanity” confirmations (non-exhaustive but covering the critical failure modes):

- **Data–design alignment:** All treatment cohorts used for identified effects (2014, 2016, 2018, 2020) occur within the stated outcome window (2012–2020), and each has at least one post-treatment observation in the biennial panel as defined. States authorizing after 2020 are consistently treated as not-yet-treated within-window.
- **Regression sanity:** Table 3 reports plausible magnitudes for an outcome in proportions (ATT ≈ −0.01), plausible SEs (≈ 0.006), and finite p-values/CIs (no NaN/Inf/NA; no absurd SE-to-coefficient ratios).
- **Completeness:** The main estimand table (Table 3) reports uncertainty (SE, p-value, CI) and reports **N in the table notes**; figures/tables referenced in the excerpt appear to exist in the provided pages; robustness mentioned in Appendix B is shown in Table 3.
- **Internal consistency:** The headline estimate in the abstract (−1.3 pp; SE 0.6 pp; p = 0.041) matches Table 3’s primary specification (−0.013; 0.006; 0.041). The pre-trends p-value (0.12) matches the event-study text.

ADVISOR VERDICT: PASS